Hikma Pharmaceuticals PLC (HKMPF)

Market Cap	5.33B
Revenue (ttm)	3.22B
Net Income (ttm)	371.00M
Shares Out	n/a
EPS (ttm)	1.67
PE Ratio	14.37
Forward PE	10.15
Dividend	0.84 (3.43%)
Ex-Dividend Date	Aug 14, 2025

Volume	2,223
Average Volume	1,316
Open	24.50
Previous Close	24.36
Day's Range	24.50 - 24.50
52-Week Range	22.56 - 28.92
Beta	0.66
RSI	44.40
Earnings Date	Aug 7, 2025

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 9,500
• Stock Exchange: OTCMKTS
• Ticker Symbol: HKMPF

Financial Performance

In 2024, Hikma Pharmaceuticals's revenue was $3.13 billion, an increase of 8.77% compared to the previous year's $2.88 billion. Earnings were $359.00 million, an increase of 88.95%.